Imaging fungal infections in children

Dornbusch HJ, Manzoni P, Roilides E, Walsh TJ, Groll AH (2009) Invasive fungal infections in children. Pediatr Infect Dis J 28(8):734–737. doi: 10.1097/INF.0b013e3181b076b1

Ozsevik SN, Sensoy G, Karli A, Albayrak C, Dagdemir A, Belet N et al (2015) Invasive fungal infections in children with hematologic and malignant diseases. J Pediatr Hematol Oncol 37(2):e69–e72. doi: 10.1097/MPH.0000000000000225

De Pascale G, Tumbarello M (2015) Fungal infections in the ICU: advances in treatment and diagnosis. Curr Opin Crit Care 21(5):421–429. doi: 10.1097/MCC.0000000000000230

Brissaud O, Guichoux J, Harambat J, Tandonnet O, Zaoutis T (2012) Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care 2(1):6. doi: 10.1186/2110-5820-2-6

Steinbach WJ (2010) Epidemiology of invasive fungal infections in neonates and children. Clin Microbiol Infect 16(9):1321–1327. doi: 10.1111/j.1469-0691

Posfay-Barbe KM, Zerr DM, Pittet D (2008) Infection control in paediatrics. Lancet Infect Dis 8(1):19–31. doi: 10.1016/S1473-3099(07)70310-9

Blyth CC, Palasanthiran P, O’Brien TA (2007) Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics 119(4):772–784. doi: 10:1542/peds.2006-2931

Kullberg BJ, Arendrup MC (2015) Invasive Candidiasis. N Engl J Med 373(15):1445–1456. doi: 10.1056/NEJMra1315399

Rammaert B, Desjardins A, Lortholary O (2012) New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidiasis. Mycoses 55(3):e74–e84. doi: 10.1111/j.1439-0507.2012.02182.x

Kosmidis C, Denning DW (2015) Republished: the clinical spectrum of pulmonary aspergillosis. Postgrad Med J 91(1077):403–410. doi: 10.1136/postgradmedj-2014-206291rep

Ahmad Sarji S, Wan Abdullah W, Wastie M (2006) Imaging features of fungal infection in immuno-suppressed patients in a local ward outbreak. Biomed Imaging Interv J 2(2):e21. doi: 10.2349/biij.2.2.e21

Altini C, Niccoli Asabella A, Ferrari C, Rubini D, Dicuonzo F, Rubini G (2015) (18)F-FDG PET/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis. Hell J Nucl Med 18(1):68–70. doi: 10.1967/s002449910167

Lehrnbecher T, Groll AH (2011) Invasive fungal infections in the pediatric population. Expert Rev Anti Infect Ther 9(3):275–278. doi: 10.1586/eri.11.1

Levy O, Martin S, Eichenwald Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM (1999) Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104(6):1327–1333

Yossuck P, Nightengale BJ, Fortney JE, Gibson LF (2008) Effect of morphine sulfate on neonatal neutrophil chemotaxis. Clin J Pain 24(1):76–82. doi: 10.1097/AJP.0b013e3181582c76

Lehrnbecher T, Foster C, Vazquez N, Mackall CL, Chanock SJ (1997) Therapy-induced alterations in host defense in children receiving chemotherapy. J Ped Hematol. Oncol 19:399–417

Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the USA: a propensity analysis. Clin Infect Dis 41(9):1232–1239

Zaoutis T, Walsh TJ. Antifungal therapy for neonatal candidiasis (2007) Curr Opin Infect Dis 20(6):592–7

Malani PN, Bradley SF, Little RS, Kauffman CA (2001) Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses 44(11–12):446–449

Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W et al (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37(5):634–643

Burgos A, Zaoutis TE, Dvorak C, Hoffman JA, Knapp KM, Nania JJ, Prasad P, Steinbach WJ (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121(5):e1286–e1294. doi: 10.1542/peds.2007-2117

Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ (2006) Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the USA, 2000. Pediatrics 117(4):e711–e716

Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA et al (2007) Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis 26(8):723–727

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41(5):634–653

Miceli MH, Maertens J (2015) Role of non-culture-based tests, with an emphasis on galactomannan testing for the diagnosis of invasive Aspergillosis. Semin Respir Crit Care Med 36(5):650–661. doi: 10.1055/s-0035-1562892

Dekio F, Bhatti TR, Zhang SX, Sullivan KV (2015) Positive impact of fungal histopathology on immunocompromised pediatric patients with histology-proven invasive fungal infection. Am J Clin Pathol 144(1):61–67. doi: 10.1309/AJCPEMVYT88AVFKG

Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G (2014) Invasive fungal infections in the ICU: how to approach, how to treat. Molecules 19(1):1085–1119. doi: 10.3390/molecules19011085

Ramos-Martín V, O’Connor O, Hope W (2015) Clinical pharmacology of antifungal agents in pediatrics: children are not small adults. Curr Opin Pharmacol 24:128–134. doi: 10.1016/j.coph.2015.08.009

Koltze A, Rath P, Schöning S, Steinmann J, Wichelhaus TA, Bader P, Bochennek K, Lehrnbecher T (2015) β-D-Glucan screening for detection of invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 53(8):2605–2610. doi: 10.1128/JCM.00747-15

De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821. doi: 10.1086/588660

Bochennek K, Abolmaali N, Wittekindt B, Schwabe D, Klingebiel T, Lehrnbecher T (2006) Diagnostic approaches for immunocompromised paediatric patients with pulmonary infiltrates. Clin Microbiol Infect 12(3):199–201

Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O et al (2002) Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20(7):1898–1906

Steinbach WJ, Addison RM, McLaughlin L, Gerrald Q, Martin PL, Driscoll T et al (2007) Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis 26(7):558–564

Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ (2007) Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Clin Vaccine Immunol 14(7):924–925

Pfaller MA, Wolk DM, Lowery TJ (2015) T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. [Epub ahead of print]

Pemán J, Zaragoza R (2010) Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 53(5):424–433. doi: 10.1111/j.1439-0507.2009.01732.x

Kim JH, Kang BC, Lee JH, Jang YJ, Lee BJ, Chung YS (2015) The prognostic value of gadolinium-enhanced magnetic resonance imaging in acute invasive fungal rhinosinusitis. J Infect 70(1):88–95. doi: 10.1016/j.jinf.2014.07.027

Yen TY, Huang LM, Lee PI, Lu CY, Shao PL, Chang LY (2011) Clinical characteristics of hepatosplenic fungal infection in pediatric patients. J Microbiol Immunol Infect 44(4):296–302. doi: 10.1016/j.jmii.2010.08.005

Fuster D, Tomás X, Granados U, Soriano A (2015) Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis: response to comments by Soussan. Eur J Nucl Med Mol Imaging 42(2):356–357. doi: 10.1007/s00259-014-2927-z

Starkey J, Moritani T, Kirby P (2014) MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol 24(3):217–230. doi: 10.1007/s00062-014-0305-7

Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L et al (2001) Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 19(1):253–259

Allan BT, Patton D, Ramsey NK, Day DL (1988) Pulmonary fungal infections after bone marrow transplantation. Pediatr Radiol 18(2):118–122

Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C (1993) CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 23(3):177–180

Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33(7):453–460

Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33(7):453–460

Demirkazik FB, Akin A, Uzun O, Akpinar MG, Ariyürek MO (2008) CT findings in immunocompromised patients with pulmonary infections. Diagn Interv Radiol 14(2):75–82

Signore A, Glaudemans AW (2011) The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med 25(10):681–700. doi: 10.1007/s12149-011-0521-z

Glaudemans AWJM. (2014) Nuclear medicine strategies to image infectious and inflammatory diseases. Dissertation, University of Groningen

Sharma P, Mukherjee A, Karunanithi S, Bal C, Kumar R (2014) Potential role of 18F-FDG PET/CT in patients with fungal infections. AJR Am J Roentgenol 203(1):180–189. doi: 10.2214/AJR.13.11712

Hot A, Maunoury C, Poiree S, Lanternier F, Viard JP, Loulergue P et al (2011) Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 17(3):409–417. doi: 10.1111/j.1469-0691.2010.03301.x

Bleeker-Rovers CP, Warris A, Drenth JP, Corstens FH, Oyen WJ, Kullberg BJ (2005) Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 11(6):493–495

Avet J Jr, Granjon D, Prevot-Bitot N, Isnardi V, Berger C, Stephan JL et al (2009) Monitoring of systemic candidiasis by 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 36(11):1900. doi: 10.1007/s00259-009-1255-1

Kono M, Yamashita H, Kubota K, Kano T, Mimori A (2015) FDG PET imaging in Pneumocystis Pneumonia. Clin Nucl Med 40(8):679–681. doi: 10.1097/RLU.0000000000000831

Vahid B, Wildemore B, Nguyen C, Sistrun N, Marik PE (2006) Pulmonary blastomycosis masquerading as metastatic disease in the lung: a case report. Med Gen Med 8(1):31

Dang CJ, Li YJ, Zhan FH, Shang XM (2012) The appearance of pulmonary mucormycosis on FDG PET/CT. Clin Nucl Med 37(8):801–803. doi: 10.1097/RLU.0b013e31825ae470

O’Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS (1997) PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38(10):1575–1583

Liu Y, Wu H, Huang F, Fan Z, Xu B (2013) Utility of 18F-FDG PET/CT in diagnosis and management of mucormycosis. Clin Nucl Med 38(9):e370–e371. doi: 10.1097/RLU.0b013e3182867d13

Reyes N, Onadeko OO, Luraschi-Monjagatta Mdel C, Knox KS, Rennels MA, Walsh TK, Ampel NM (2014) Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung 192(4):589–593. doi: 10.1007/s00408-014-9589-2

Wang J, Ju HZ, Yang MF (2014) Pulmonary cryptococcosis and cryptococcal osteomyelitis mimicking primary and metastatic lung cancer in (18)F-FDG PET/CT. Int J Infect Dis 18:101–103. doi: 10.1016/j.ijid.2013.08.009

Croft DR, Trapp J, Kernstine K, Kirchner P, Mullan B, Galvin J, Peterson MW et al (2002) FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 36(3):297–301

Hamerschlak N, Pasternak J, Wagner J, Perini GF (2012) Not all that shines is cancer: pulmonary cryptococcosis mimicking lymphoma in [(18)] F fluoro-2-deoxy-d-glucose positron emission tomography. Einstein (Sao Paulo) 10(4):502–504

Igai H, Gotoh M, Yokomise H (2006) Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-d-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer. Eur J Cardiothorac Surg 30(6):837–839

Salhab KF, Baram D, Bilfinger TV (2006) Growing PET positive nodule in a patient with histoplasmosis: case report. J Cardiothorac Surg 1:23

Ozsahin H, von Planta M, Müller I, Steinert HC, Nadal D, Lauener R et al (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92(8):2719–2724

Franzius C, Biermann M, Hülskamp G, Frosch M, Roth J, Sciuk J et al (2001) Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med 26(3):232–233

Theobald I, Fischbach R, Hülskamp G, Franzius C, Frosch M, Roth J, Heindel W (2002) Pulmonary aspergillosis as initial manifestation of septic granulomatosis (chronic granulomatous disease, CGD) in a premature monozygotic female twin and FDG-PET diagnosis of spread of the disease. Radiologe 42(1):42–45

Camus V, Edet-Sanson A, Bubenheim M, Hitzel A, Becker S, David M et al (2015) 18F-FDG-PET/CT Imaging in patients with Febrile Neutropenia and Haematological Malignancies. Anticancer Resn 35(5):2999–3005

Wilkinson MD, Fulham MJ, McCaughan BC, Constable CJ (2003) Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med 28(3):234–235

Sonet A, Graux C, Nollevaux MC, Krug B, Bosly A, Vander Borght T (2007) Unsuspected FDG-PET findings in the follow-up of patients with lymphoma. Ann Hematol 86(1):9–15

Nishikawa T, Kagawa T, Matsumi Y, Fujiwara T, Kataoka K, Matsuura M (2011) Lung cancer associated with pulmonary aspergillosis in the nodule of old mycobacterial infection. Kyobu Geka 64(3):231–234

Ahn BC, Lee SW, Lee J, Kim C (2011) Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer. Thyroid 21(5):555–558

Baxter CG, Bishop P, Low SE, Baiden-Amissah K, Denning DW (2011) Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography. Thorax 66(7):638–640. doi: 10.1136/thx.2010.155515

Xu B, Shi P, Wu H, Guo X, Wang Q, Zhou S (2010) Utility of FDG PET/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis. Clin Nucl Med 35(8):567–570. doi: 10.1097/RLU.0b013e3181e4db84

Kim JY, Yoo JW, Oh M, Park SH, Shim TS, Choi YY, Ryu JS (2013) (18)F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography findings are different between invasive and noninvasive pulmonary aspergillosis. J Comput Assist Tomogr 37(4):596–601. doi: 10.1097/RCT.0b013e318289aa3

Bleeker-Rovers CP, Vos FJ, Wanten GJ, van der Meer JW, Corstens FH, Kullberg BJ, Oyen WJ (2005) 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 46(12):2014–2019

Tibúrcio FR, de Sá Rodrigues KE, Vasconcelos HM, Miranda DM, Simões e Silva AC (2015) Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report. BMC Pediatr 15:108. doi: 10.1186/s12887-015-0427-3

Altinmakas E, Guo M, Kundu UR, Habra MA, Ng C (2015) Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging 39(6):1115–1118. doi: 10.1016/j.clinimag.2015.07.010

Karunanithi S, Kumar G, Sharma SK, Jain D, Gupta A, Kumar R (2015) Staging and response of sternal histoplasmosis by 18F-FDG PET/CT. Clin Nucl Med 40(3):231–233. doi: 10.1097/RLU.0000000000000578

Nakazato T, Mihara A, Sanada Y, Suzuki K, Aisa Y, Iwabuchi M, Kakimoto T (2010) Pneumocystis jiroveci pneumonia detected by FDG-PET. Ann Hematol 89(8):839–840. doi: 10.1007/s00277-009-0888-2

Miyazaki Y, Nawa Y, Nakase K, Kohashi S, Kadohisa S, Hiraoka A et al (2011) FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings. Ann Hematol 90(12):1489–1490. doi: 10.1007/s00277-011-1204-5

Roux S, Ferry T, Chidiac C, Bouaziz A, Ninet J, Pérard L et al (2014) Infectious thoracic aortic aneurysms: 7 cases and literature review. Rev Med Interne 35(6):357–364. doi: 10.1016/j.revmed.2013.09.004

Wallner M, Steyer G, Krause R, Gstettner C, von Lewinski D (2013) Fungal endocarditis of a bioprosthetic aortic valve. Pharmacological treatment of a Candida parapsilosis endocarditis. Herz 38(4):431–434. doi: 10.1007/s00059-012-3715-9

Morooka M, Ito K, Kubota K, Minamimoto R, Shida Y, Hasuo K, Ito T, Tasato D, Honda H, Teruya K, Kikuchi Y, Ohtomo K (2010) Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy. Jpn J Radiol. 28(10):759–762. doi: 10.1007/s11604-010-0481-6

Shrikanthan S, Aydin A, Dhurairaj T, Alavi A, Zhuang H (2005) Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging. Clin Nucl Med 30(10):695–697

Teyton P, Baillet G, Hindié E, Filmont JE, Sarandi F, Toubert ME et al (2009) Hepatosplenic candidiasis imaged with F-18 FDG PET/CT. Clin Nucl Med 34(7):439–440. doi: 10.1097/RLU.0b013e3181a7cfba

Hanson MW, Glantz MJ, Hoffman JM, Friedman AH, Burger PC, Schold SC et al (1991) FDG-PET in the selection of brain lesions for biopsy. J Comput Assist Tomogr 15(5):796–801

Padma S, Sreehar S (2014) 18F FDG PET/CT identifies unsuspected bilateral adrenal histoplasmosis in an elderly immuno compromised patient. Indian J Med Res 139(5):786–787

Kasaliwal R, Malhotra G, Bukan A, Asopa RV, Wanjare S, Shah NS (2014) 18F-FDG PET as a monitoring tool to assess treatment response in bilateral adrenal histoplasmosis. Clin Nucl Med 39(6):576–578. doi: 10.1097/RLU.0000000000000400

Tsai YJ, Lin YH, Hsu CH, Yeh SD (2013) 18F-fluorodeoxyglucose positron emission tomography for the initial evaluation and monitoring of therapeutic response in bilateral adrenal histoplasmosis. Clin Imaging 37(4):791–793. doi: 10.1016/j.clinimag.2013.02.011

Umeoka S, Koyama T, Saga T, Higashi T, Ito N, Kamoto T et al (2005) 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol 15(12):2483–2486

Mackie GC, Pohlen JM (2005) Mediastinal histoplasmosis: F-18 FDG PET and CT findings simulating malignant disease. Clin Nucl Med 30(9):633–635

Dubbioso R, Pappatà S, Quarantelli M, D’Arco F, Manganelli F, Esposito M, Santoro L (2013) Atypical clinical and radiological presentation of cryptococcal choroid plexitis in an immunocompetent woman. J Neurol Sci 334(1–2):180–182. doi: 10.1016/j.jns.2013.08.010

Vos FJ, Bleeker-Rovers CP, Oyen WJ (2013) The use of FDG-PET/CT in patients with febrile neutropenia. Semin Nucl Med 43(5):340–348. doi: 10.1053/j.semnuclmed.2013.04.007

Chamilos G, Macapinlac HA, Kontoyiannis DP (2008) The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 46(1):23–29. doi: 10.1080/13693780701639546

Ritz N, Ammann RA, Aebischer CC, Gugger M, Jaton K, Schmid RA, Aebi C (2005) Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr 164:231–235

Ho AY, Pagliuca A, Maisey MN, Mufti GJ (1998) Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol 101:392–393. doi: 10.1046/j.1365-2141.1998.0738e.x

Go KG, Pruim TH, Que TH, Vaalburg W, Haaxma-Reiche H (2000) Evaluation of dissemination studies with FDG whole-body positron emission tomography in patients with suspected metastatic tumours of brain and spine. Acta Neurochir 142:627–631

Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ et al (2001) 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19:3516–3523

Kawabe J, Okamura T, Koyama K, Shakudo M, Sakamoto H, Kobashi T et al (1998) Relatively high F-18 fluorodeoxyglucose uptake in paranasal sinus aspergillosis: a PET study. Ann Nucl Med 12:145–148

Hanson MW, Glantz MJ, Hoffman JM, Friedman AH, Burger PC, Schold SC, Coleman RE (1991) FDG-PET in the selection of brain lesions for biopsy. J Comput Assist Tomogr 15:796–801

Glaudemans AW, Quintero AM, Signore A (2012) PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging 39(5):745–749. doi: 10.1007/s00259-012-2060-9

de Jonge F, van Rheenen R (2015) Sunny and Tim: Wil jij fotodokter helpen?. Bohn Stafleu van Loghum, Houten

Lupetti A, de Boer MG, Erba P, Campa M, Nibbering PH (2011) Radiotracers for fungal infection imaging. Med Mycol 49(Suppl 1):S62–S69. doi: 10.3109/13693786.2010.508188

Fischman AJ, Alpert NM, Livni E, Ray S, Sinclair I, Elmaleh DR, Weiss S, Correia JA, Webb D, Liss R et al (1991) Pharmacokinetics of 18F-labeled fluconazole in rabbits with candidal infections studied with positron emission tomography. J Pharmacol Exp Ther 259(3):1351–1359

Petrik M, Vlckova A, Novy Z, Urbanek L, Haas H, Decristoforo C (2015) Selected 68Ga-siderophores versus 68Ga-colloid and 68Ga-citrate: biodistribution and small animal imaging in mice. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(1):60–66. doi: 10.5507/bp.2014.052

Kumar V, Boddeti DK, Evans SG, Angelides S (2012) 68 Ga-Citrate-PET for diagnostic imaging of infection in rats and for intra-abdominal infection in a patient. Curr Radiopharm 5:71–75

Kumar V, Boddeti DK (2013) (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation. Recent Results Cancer Res 194:189–219. doi: 10.1007/978-3-642-27994-2_11

Siaens R, Eijsink VG, Vaaje-Kolstad G, Vandenbulcke K, Cornelissen B, Cuvelier C, Dierckx R, Slegers G (2006) Synthesis and evaluation of a 99mTechnetium labeled chitin-binding protein as potential specific radioligand for the detection of fungal infections in mice. Q J Nucl Med Mol Imaging 50(3):155–166

Siaens R, Eijsink VG, Dierckx R, Slegers G (2004) [123]I-Labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice. J Nucl Med 45(7):1209–1216

Vos FJ, Donnelly JP, Oyen WJ, Kullberg BJ, Bleeker-Rovers CP et al (2012) 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation. Eur J Nucl Med Mol Imaging 39:120–128. doi: 10.1007/s00259-011-1939-1